ValueScreener company report

Globe Life Inc. (GL)

Name: Globe Life Inc. (GL) filed financial figures
Creator: ValueScreener

NYSE / Financial Services / Insurance - Life

Share price

167.59 USD Market dataClose of Oct 15, 2026

Market capitalisation

12.88B USD Market dataClose of Oct 15, 2026

Market data: Oct 15, 2026
Filed accounts: FY2025, filed Feb 25, 2026
Ratios computed: Oct 15, 2026
Filed years: 18, FY2007 to FY2025

Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means

SEC filingFiled with the SEC: Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement: What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data: Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener: Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.

Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Quality

Return on equity

19.4% Computed

From the FY2025 filing

Read quality

Financial strength

Debt to equity

n/a Computed

From the FY2025 filing

Why n/a

The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.

Read financial strength

Valuation

Price to earnings

11.74x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Dividend yield

0.8% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, as filed

Revenue Net income10 filed fiscal years, from the annual reports; the table in Filings names each document.

Named tests met: 1 of 30 Which tests

The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 11.74x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 10.00x and 15.00x.

Today, against the Financial Services sector (657 companies), 11.74x sits at the 28th percentile; the middle half of that group runs from 11.29x to 24.29x.

Is it good

Return on equity was 19.4% in FY2025, in the band labelled "Strong" (15.0% to 25.0%), on lines anchored on Damodaran's cost-of-capital data, suggesting high returns on shareholders' money, which leverage can also produce.

Today, against the Financial Services sector (739 companies), 19.4% sits at the 85th percentile; the middle half of that group runs from 3.6% to 13.7%.

Year by year against peers: Whether Globe Life Inc.'s return on equity stayed above the median of the Financial Services sector, year by year. (FY2016 to FY2025, 10 fiscal years of Globe Life Inc. with a comparable figure)
The direction: Which way Globe Life Inc.'s return on equity has moved, and how steadily. (FY2016 to FY2025, 10 filed years of Globe Life Inc.)
What could explain it: What in Globe Life Inc.'s filed statements could explain the movements. (3 readings drawn from the statement lines Globe Life Inc. filed)
What to check next: What to check next on Globe Life Inc., and where in its filings. (1 question for Globe Life Inc.)
In one paragraph: One paragraph on Globe Life Inc.'s returns, cash, balance sheet and price. (4 of sixteen figures read for Globe Life Inc.)

These are GL’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research GLPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 25, 2026, accession 0000320335-26-000090.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Globe Life Inc: returns on capital and margins, each with its source
Figure	Value, source and document
Return on invested capital, after tax Why n/m Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Return on equity	19.4% ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Return on capital employed, pre-tax Why n/m Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Return on assets	3.8% ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Gross margin Why n/a No gross profit line is filed for this year.	n/a ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Operating margin Why n/a No operating income line is filed for this year.	n/a ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Net margin	19.4% ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090

GL 19.4%

4.4%34.6%

Net margin: GL against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Globe Life Inc: leverage, liquidity and distress, each with its source
Figure	Value, source and document
Debt to equity Why n/a The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.	n/a ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Current ratio Why n/m Banks and insurers present an unclassified balance sheet under Regulation S-X, with no split between current and non-current. A current ratio needs that split, so there is none to show.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Quick ratio Why n/m Banks and insurers present an unclassified balance sheet under Regulation S-X, with no split between current and non-current. A current ratio needs that split, so there is none to show.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Interest coverage Why n/a No operating income line is filed for this year.	n/a ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Altman Z-score Why n/m Altman's Z-Score was estimated on manufacturers and explicitly excludes financial firms. A financial company scores in the distress zone by construction, so the number would be wrong rather than alarming. Not applicable to financials.	n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Net debt Why n/a The FY2025 balance sheet carries no net debt we could read.	n/a ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090

Total assets Total liabilities Shareholders’ equity

The balance sheet, line by line

Financial health

What Globe Life Inc owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 25, 2026, 0000320335-26-000090).

Globe Life Inc: balance sheet position
Total assets	30.81B FiledFY2025 10-K, filed Feb 25, 2026
Total liabilities	24.84B FiledFY2025 10-K, filed Feb 25, 2026
Shareholders' equity	5.97B FiledFY2025 10-K, filed Feb 25, 2026
Cash	459.4M FiledFY2025 10-K, filed Feb 25, 2026
Total debt	n/a FiledFY2025 10-K, filed Feb 25, 2026
Net debt	n/a
Current ratio	n/m
Debt to equity	n/a

Debt to equity: FY2025: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
Current ratio: FY2025: Banks and insurers present an unclassified balance sheet under Regulation S-X, with no split between current and non-current. A current ratio needs that split, so there is none to show.
Interest cover: FY2025: No operating income line is filed for this year.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Globe Life Inc: what the market charges, each with its source
Figure	Value, source and document
Price to earnings	11.74x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
P/E on trailing twelve months	11.12x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book	2.31x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Price to sales	2.31x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Enterprise value to EBIT Why n/m Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.	n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Enterprise value to EBITDA Why n/m Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.	n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Price to earnings over growth	0.75 ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Diluted earnings per share	14.07 USD FiledFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Graham number	152.46 USD ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090

We publish no fair value or price target of our own. Value GL on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Globe Life Inc today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Globe Life Inc: valuation
Share price	167.59 USD
Market capitalisation	12.88B USD
Enterprise value to EBITDA	n/m
Graham number	152.46 USD
Diluted earnings per share, FY2025	14.07 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Oct 3, 2016: low 4.88x, median 11.97x, high 19.94x, latest 11.12x. 2,522 trading days with a meaningful ratio. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Globe Life Inc

Same industry (Insurance - Life) and size band (Large, 10B to 200B), nearest in market value and net margin. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Globe Life Inc: cash generation and what is paid out, each with its source
Figure	Value, source and document
Free cash flow yield Why n/m For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.	n/m ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Free cash flow	1.25B USD ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Free cash flow margin Why n/m For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Dividend yield	0.8% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Payout ratio	7.4% ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090

Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Globe Life Inc.: the eight ratios, with the fiscal year and filing date behind each.
Figure	Value	Year	As of
	11.74x	FY2025	Oct 15, 2026
FormulaShare price / earnings per share. Where the filing states no earnings per share this listing can be priced on, which is every 20-F and 40-F filer because theirs is stated per ordinary share, it is market capitalisation / net income: the same multiple, undiluted. As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	2.31x	FY2025	Oct 15, 2026
FormulaMarket capitalisation / shareholders equity As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
Formula(Market capitalisation + total debt - cash) / operating income, or over the filing's own EBIT (income before tax + interest expense) where the filer tags no operating line, as Johnson & Johnson does not in any of its ten filed years. As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
FormulaFree cash flow per share / share price x 100 As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Feb 25, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
FormulaVendor trailing-twelve-month return on invested capital where one is published, which uses after-tax operating profit over total assets less current liabilities. Otherwise our own recompute: NOPAT / (shareholders equity + total debt - cash) x 100, where NOPAT is the filed operating profit after tax, or the filing's own EBIT after tax where the filer tags no operating line. As ofThe filing date of the statements below, for FY2025. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	0.8%	FY2025	Oct 15, 2026
FormulaCommon dividends paid in the latest filed year / market capitalisation x 100. n/a where the filing cannot support it: a special or first-year payment, a total that mixes preferred dividends, or a cash-flow statement over 15 months old. As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/a	FY2025	Feb 25, 2026
n/a The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
FormulaTotal debt / shareholders equity As ofThe filing date of the statements below, for FY2025. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Feb 25, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
FormulaCurrent assets / current liabilities As ofThe filing date of the statements below, for FY2025. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	2.31x	FY2025	Oct 15, 2026
FormulaMarket capitalisation / revenue As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	0.75	FY2025	Oct 15, 2026
FormulaPrice to earnings / the annual earnings growth rate, in percentage points As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
Formula1.2 x working capital/assets + 1.4 x retained earnings/assets + 3.3 x EBIT/assets + 0.6 x market value of equity/total liabilities + 1.0 x revenue/assets As ofThe close on Oct 15, 2026, over the filed figures of FY2025: a price is in this figure, and it moved after the filing. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Feb 25, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
FormulaAn eight-variable index of year-on-year changes in receivables, gross margin, asset quality, revenue, depreciation, overheads, leverage and accruals As ofThe filing date of the statements below, for FY2025. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab
	n/m	FY2025	Feb 25, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
FormulaOne point each for: positive return on assets, positive operating cash flow, rising return on assets, operating cash flow above net income, falling leverage, rising current ratio, no new shares issued, rising gross margin, rising asset turnover. As ofThe filing date of the statements below, for FY2025. Form10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itIncome statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itBalance sheetFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tabForm10-KFiledFeb 25, 2026PeriodFY2025Accession0000320335-26-000090What we read from itCash flow statementFY2025Open on SEC.gov, accession 0000320335-26-000090, leaves this page and opens in a new tab

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 18 filed fiscal years on record, FY2007 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

10 filed fiscal years, FY2016 to FY2025, read from the annual reports Globe Life Inc filed with the SEC. Each year names its filing. Amounts in USD, as filed.

Globe Life Inc: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
Year	Revenue	Operating income	Net income	EPS, diluted	Free cash flow	Operating margin	Return on equity	Filing
FY2025	5.99B	1.58B	1.16B	14.07	1.25B	n/a	19.4%	10-K, Feb 25, 20260000320335-26-000090
FY2024	5.78B	1.45B	1.07B	11.94	1.33B	n/a	20.2%	10-K, Feb 26, 20250000320335-25-000013
FY2023	5.45B	1.27B	970.8M	10.07	1.43B	23.2%	21.6%	10-K, Feb 28, 20240000320335-24-000006
FY2022	5.23B	1.19B	894.4M	9.04	1.39B	22.7%	22.6%	10-K, Feb 23, 20230000320335-23-000008
FY2021	5.11B	1.23B	1.03B	9.99	1.40B	24.0%	51.5%	10-K, Feb 24, 20220000320335-22-000006
FY2020	4.74B	905.4M	731.8M	6.82	1.43B	19.1%	8.3%	10-K, Feb 25, 20210000320335-21-000010
FY2019	4.53B	920.1M	760.8M	6.83	1.32B	20.3%	10.4%	10-K, Feb 27, 20200000320335-20-000008
FY2018	4.30B	870.6M	701.5M	6.09	1.23B	20.2%	12.9%	10-K, Mar 1, 20190000320335-19-000006
FY2017	4.16B	821.2M	1.45B	12.22	1.41B	19.8%	23.3%	10-K, Feb 27, 20180000320335-18-000006
FY2016	3.93B	787.3M	549.8M	4.49	1.37B	20.0%	12.0%	10-K, Feb 27, 20170000320335-17-000010

Revenue, compound annual growth FY2016 to FY2025: 4.8%
Earnings, compound annual growth FY2016 to FY2025: 8.7%
Earnings per share, compound annual growth FY2016 to FY2025: 13.5%
Free cash flow, compound annual growth FY2016 to FY2025: -1.0%

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Globe Life Inc: accounting screens and published tests, each with its source
Figure	Value, source and document
Beneish M-score Why n/m The Beneish M-Score is built on gross margin, receivables and asset quality indices estimated on non-financial firms. Those inputs are not defined here.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Piotroski F-score Why n/m 4 of the nine Piotroski signals are undefined for an insurer: signal 5 (falling long-term leverage), signal 6 (rising current ratio), signal 8 (rising gross margin), signal 9 (rising asset turnover). We do not publish a partial score under the full score's name.	n/m ComputedFY2025 10-K, filed Feb 25, 2026, 0000320335-26-000090
Named tests met	1 of 30 Computed
Beta	0.46 ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 1 met, 14 not met, 15 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)

Meets: Cheapest quarter on P/E (David Dreman)
Does not: Defensive investor (Benjamin Graham); Deep value; High F-score, low P/B (Joseph Piotroski); High returns and growth; High yield, low payout; Dividends and buybacks; Near the 52-week low; P/E times P/B (Benjamin Graham); High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured: Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); Three forensic scores; Low PEG, low debt (Peter Lynch); Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; Low beta, profitable; ROIC at or above WACC; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); High returns, low debt; Owner earnings yield; Cash-covered dividend; Cash-flow yield and ROIC; Clean books, high ROIC. A test with a figure we could not read is incomplete, never met and never failed.

Figures we could not read(17)

Current Ratio: Banks and insurers present an unclassified balance sheet under Regulation S-X, with no split between current and non-current. A current ratio needs that split, so there is none to show.
Debt to Equity: The debt total on file was summed from short-term debt, long-term debt and lease obligations, and at least one of those was never captured. An absent term is spent as a zero inside that sum, and this balance sheet does not show the term is empty, so we will not build a leverage ratio, an enterprise value or a return on capital on it, or rank the company on one.
Piotroski F-Score: 4 of the nine Piotroski signals are undefined for an insurer: signal 5 (falling long-term leverage), signal 6 (rising current ratio), signal 8 (rising gross margin), signal 9 (rising asset turnover). We do not publish a partial score under the full score's name.
EV/EBIT: Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.
Return on Invested Capital: Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.
Altman Z-Score: Altman's Z-Score was estimated on manufacturers and explicitly excludes financial firms. A financial company scores in the distress zone by construction, so the number would be wrong rather than alarming. Not applicable to financials.
Beneish M-Score: The Beneish M-Score is built on gross margin, receivables and asset quality indices estimated on non-financial firms. Those inputs are not defined here.
Gross Margin: No gross profit line is filed for this year.
Asset Turnover: A lender's assets are loans and securities that earn interest, not plant used to produce sales. Revenue over assets is not a turnover measure here.
EV/EBITDA: Enterprise value adds debt and subtracts cash. For a financial company both are the business itself, so the resulting multiple has no economic meaning.
Interest Coverage: No operating income line is filed for this year.
Free Cash Flow Yield: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.
ROIC-WACC Spread: Invested capital is equity plus debt less cash. A financial company's debt and cash are operating positions, so returns measured against that base are not comparable to an operating business.
Price To Ncav: Net current asset value needs current assets, which an unclassified balance sheet does not report.
Owner Earnings Yield: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.
Capex To Ocf: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.
Dividend Coverage Ratio: For a bank, an insurer, a broker or investment firm, or a mortgage trust, operating cash flow swings with the size of the loan, trading and funding book rather than with operating performance, so free cash flow is not the measure of the business. Look at earnings and capital adequacy.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

Value it in the DCF workbench

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

What this cannot tell you

17 figures could not be read on this company, among them Current Ratio, Debt to Equity, Piotroski F-Score. Each blank in the table above names the rest, with its reason. 15 named tests come back incomplete because of them, which is neither met nor missed.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolio How this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Four questions, at a glance

Quality

Financial strength

Valuation

Cash generation

Revenue and net income, as filed

The reading, in brief

Financial health

Valuation

Companies like Globe Life Inc

The filed figures

Ten years of filed figures

The named tests

What this cannot tell you

Margin Notes